Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
270 Leser
Artikel bewerten:
(0)

InfoLogix Announces Partnership With CareTrends Systems to Increase Nursing Efficiency and Speed the Adoption of EMR

HATBORO, Pa., Feb. 23 /PRNewswire-FirstCall/ -- InfoLogix, Inc. , a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO )

InfoLogix empowers, mobilizes and manages healthcare solutions for 1,500 hospitals, helping to ensure that information from their systems is available at the precise location where it has maximum impact. CareTrends LLC is the developer of careTrends®, an enterprise software and wireless vital signs collection and dissemination system, engineered to improve quality of patient care and decrease healthcare costs. With new market demands driven by ARRA stimulus legislation, regulatory mandates, and hospitals' competitive pressures, the companies will automate vital signs documentation and trending, and make the information accessible from any point within a healthcare organization's systems.

"As hospitals continue to focus on EMR implementation and meeting rapidly evolving regulatory mandates, it's critical to ensure that newly digitized healthcare information is available at the point of care, wherever that may be," says David Gulian, president and CEO of InfoLogix. "By combining InfoLogix's expertise in mobilizing caregivers with information at the precise point where it has maximum impact, and CareTrends' expertise in vital signs monitoring, we look forward to advancing efficiency and quality of care for the many healthcare organizations that we serve."

"For healthcare organizations, having immediate access to accurate vital signs data is one of the key factors in successfully achieving the digital hospital of tomorrow," says Satinder Singh, CEO of CareTrends. "As we build upon a decade of successful experience in enhancing the quality of care with automated vital signs monitoring, we look forward to extending our capabilities to InfoLogix's customer base across North America and beyond."

Executives from InfoLogix and CareTrends will be available to take questions from customers and the media at HIMSS 2010 in Atlanta, March 1-4 at the Atlanta Convention Center Booth #2621. Please visit http://www.infologix.com/healthcare or http://www.caretrendssystems.com/ for more information.

About InfoLogix, Inc.

InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company '. For more information visit http://www.infologix.com/.

About CareTrends LLC

CareTrends is a leading healthcare information technology systems company that provides integration and intelligence software for the global patient monitoring market. CareTrends' solutions address the standard of care, medical errors and nursing constraint challenges of the healthcare industry by automating the collection of patient vital signs and I/O data. The company's solutions enable healthcare providers to meet the rising demand for better care at lower costs and reduce nursing staff time spent on data collection and documentation. The result is reduced costs, fewer medical errors and improved patient care.

Media Contact for InfoLogix: Jason Fradin Vice President of Marketing 215-604-0691 x1194 jfradin@infologix.com Media Contact for CareTrends: Satinder Singh CEO 650-346-1369 Satinder@caretrendssystems.com

Photo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com

InfoLogix, Inc.

CONTACT: Jason Fradin, Vice President of Marketing of InfoLogix,
+1-215-604-0691 x1194, jfradin@infologix.com; or Satinder Singh, CEO of
CareTrends, +1-650-346-1369, Satinder@caretrendssystems.com

Web Site: http://www.infologix.com/

© 2010 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.